Related Experiment Videos
8-Aminocyclazocine analogues: synthesis and structure-activity relationships
M P Wentland1, G Xu, C L Cioffi
1Departmnent of Chemistry, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Bioorganic & Medicinal Chemistry Letters
|February 15, 2000
Summary
Researchers explored novel cyclazocine analogues, finding that secondary amine derivatives with a specific configuration showed the highest opioid receptor binding affinity. These compounds were synthesized efficiently using palladium-catalyzed amination.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- Cyclazocine is a potent opioid analgesic with a complex pharmacological profile.
- Modifications to the cyclazocine scaffold are crucial for developing novel analgesics with improved therapeutic indices.
- Understanding structure-activity relationships is key to designing selective opioid receptor ligands.
Purpose of the Study:
- To synthesize and evaluate novel cyclazocine analogues with modified 8-position substituents for opioid receptor binding.
- To investigate the impact of amino and substituted-amino groups at the 8-position on binding affinities for mu and kappa opioid receptors.
- To establish efficient synthetic routes for these novel analogues.
Main Methods:
- Synthesis of cyclazocine analogues by replacing the 8-OH group with various amino and substituted-amino moieties.
- Assessment of opioid binding affinities using radioligand binding assays for mu and kappa opioid receptors.
- Utilizing palladium-catalyzed amination reactions for the efficient synthesis of target compounds from cyclazocine triflate precursors.
Main Results:
- Several secondary amine derivatives of cyclazocine were synthesized and tested.
- The (2R,6R,11R)-configured secondary amine derivatives exhibited the highest binding affinities for both mu and kappa opioid receptors.
- Palladium-catalyzed amination proved to be an efficient method for synthesizing these cyclazocine analogues.
Conclusions:
- Novel cyclazocine analogues with potent mu and kappa opioid receptor binding have been developed.
- The stereochemistry and nature of the substituent at the 8-position significantly influence opioid receptor affinity.
- Efficient synthetic strategies enable further exploration of this chemical space for potential therapeutic agents.